The pH factor: unraveling drug-drug interactions in protein kinase inhibitors through the regulatory lens
Translational and Clinical Pharmacology · 2026 · 34 (1) · 1
DOI: 10.12793/tcp.2026.34.e6 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Translational and Clinical Pharmacology, 2026. Verfasst von Simona Stankeviciute und 3 weiteren Autor:innen. Beteiligte Einrichtung: Parexel International UAB, LT-08130 Vilnius, Lithuania. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Parexel International UAB, LT-08130 Vilnius, Lithuania.
- Parexel Netherland B.V., 1101 CC Amsterdam, Netherlands.
- Clinical Pharmacology and Safety Sciences, Research & Development, Alexion, AstraZeneca Rare Disease, Mississauga, ON L5N 0E1, Canada.
- Parexel International GmbH, 14050 Berlin, Germany.
ORCID-Profile: Simona Stankeviciute, Ariel Tsai, Noha Rayad, Matthias Kruse
Zitieren
APA
Stankeviciute, S., Tsai, A., Rayad, N., & Kruse, M. (2026). The pH factor: unraveling drug-drug interactions in protein kinase inhibitors through the regulatory lens. Translational and Clinical Pharmacology, 34(1), 1. https://doi.org/10.12793/tcp.2026.34.e6
Vancouver
Stankeviciute S, Tsai A, Rayad N, Kruse M. The pH factor: unraveling drug-drug interactions in protein kinase inhibitors through the regulatory lens. Translational and Clinical Pharmacology. 2026;34(1):1. doi:10.12793/tcp.2026.34.e6
BibTeX
@article{Stankeviciute2026,
author = {Stankeviciute, Simona and Tsai, Ariel and Rayad, Noha and Kruse, Matthias},
title = {The pH factor: unraveling drug-drug interactions in protein kinase inhibitors through the regulatory lens},
journal = {Translational and Clinical Pharmacology},
year = {2026},
volume = {34},
number = {1},
pages = {1},
doi = {10.12793/tcp.2026.34.e6}
}
EUVIMED